14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Oct 29, 2019 $3.94 $4.00 $3.80 $3.95 217 744
Oct 28, 2019 $3.98 $4.13 $3.91 $3.94 262 306
Oct 25, 2019 $3.80 $4.09 $3.69 $3.93 354 125
Oct 24, 2019 $3.95 $3.95 $3.76 $3.83 273 072
Oct 23, 2019 $4.04 $4.04 $3.79 $3.90 412 132
Oct 22, 2019 $3.99 $4.08 $3.87 $4.04 477 160
Oct 21, 2019 $4.04 $4.12 $3.96 $4.00 282 372
Oct 18, 2019 $3.97 $4.02 $3.85 $3.98 313 766
Oct 17, 2019 $4.02 $4.12 $3.95 $4.00 276 916
Oct 16, 2019 $4.00 $4.21 $3.97 $4.02 391 822
Oct 15, 2019 $3.94 $4.04 $3.85 $4.03 515 473
Oct 14, 2019 $3.74 $3.95 $3.70 $3.90 460 231
Oct 11, 2019 $3.50 $3.78 $3.40 $3.76 723 981
Oct 10, 2019 $3.53 $3.74 $3.35 $3.44 987 414
Oct 09, 2019 $3.79 $3.84 $3.41 $3.67 803 928
Oct 08, 2019 $4.14 $4.23 $3.74 $3.75 975 337
Oct 07, 2019 $4.37 $4.45 $4.03 $4.20 1 292 567
Oct 04, 2019 $4.03 $4.51 $4.00 $4.45 1 038 257
Oct 03, 2019 $4.13 $4.19 $3.94 $4.03 718 549
Oct 02, 2019 $4.29 $4.59 $4.09 $4.13 892 194
Oct 01, 2019 $5.07 $5.07 $4.17 $4.38 1 433 424
Sep 30, 2019 $6.23 $6.23 $4.85 $5.12 1 623 052
Sep 27, 2019 $7.05 $7.11 $6.55 $6.67 374 007
Sep 26, 2019 $7.37 $7.50 $7.03 $7.05 441 739
Sep 25, 2019 $7.29 $7.67 $7.29 $7.38 560 790
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT